IDXX vs VRTX: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

IDXX has stronger fundamentals based on our AI analysis.

IDXX
IDEXX LABORATORIES INC /DE
A+
82%
Confidence
VS
VRTX
VERTEX PHARMACEUTICALS INC / MA
A
81%
Confidence

IDXX vs VRTX Fundamental Comparison

Metric IDXX VRTX
Revenue $1.1B $3.0B
Net Income $278.4M $1.0B
Net Margin 24.4% 34.5%
ROE 17.9% 5.3%
ROA 8.2% 3.9%
Current Ratio 1.12x 3.02x
Debt/Equity 0.19x 0.01x
EPS $3.47 $4.02

Green = Better metric | Red = Weaker metric

View Full IDXX Analysis →
View Full VRTX Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Top Rated Undervalued Growth Dividend

You Might Also Compare

IDXX vs AAPL VRTX vs MSFT IDXX vs GOOGL VRTX vs AMZN

IDXX vs VRTX: Frequently Asked Questions

Is IDXX or VRTX the better stock in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), IDXX has stronger fundamentals. IDXX is graded A+ (82% confidence) while VRTX is graded A (81% confidence). This is not investment advice.

How does IDXX compare to VRTX fundamentally?

IDEXX LABORATORIES INC /DE has ROE of 17.9% vs VERTEX PHARMACEUTICALS INC / MA's 5.3%. Net margins are 24.4% vs 34.5% respectively.

Which stock pays higher dividends, IDXX or VRTX?

IDXX has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in IDXX or VRTX for long term?

For long-term investing, consider that IDXX has a A+ grade with 82% confidence, while VRTX has a A grade with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about IDXX vs VRTX?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IDXX vs VRTX, the AI consensus favors IDXX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.